IL6 and renal carcinoma: Thus, high IL6 levels are an additional phenotypic characteristic of the acute phase reaction for renal cancer patients with high CRP levels, whereas variation in the other acute phase cytokine mediators is not reflected by CRP in renal cancer patients.